That's a great result.
33% in August. I'm wondering
- is August representative of the quarter?
- was the result at the expense of Apotex or GSK?
- Was the improvement in retail or the still floundering non-retail sector?
- will the incr volume be reflected in this quarter's profit result, or did they sacrifice price for volume?
It will be good to see any company explanation as to how the apparent lift affects ACL. Nice to see a '3' at the start of market share though.
good fonda-brations!, page-3
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable